Franklin Street Advisors Inc Repligen Corp Transaction History

Franklin Street Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$122.51 - $158.27 $1.23 Million - $1.58 Million	-10,000 Closed	0 $0
Q1 2020 Apr 16, 2020	SELL	$84.96 - $109.14 $8,496 - $10,914	-100 Reduced 0.99%	10,000 $965,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $7,665 - $9,551	100 Added 1.0%	10,100 $775,000
Q3 2017 Oct 11, 2017	BUY	$36.98 - $46.06 $369,799 - $460,600	10,000	10,000 $383,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Franklin Street Advisors Inc with notifications on news.